Imricor Medical Systems, Inc. (ASX: IMR) Announces Strong Q4 Results
Imricor (ASX: IMR) reports significant regulatory progress and strong revenue growth, setting a positive outlook for Q4 CY24.
Imricor (ASX: IMR) reports significant regulatory progress and strong revenue growth, setting a positive outlook for Q4 CY24.
Core Lithium Ltd (ASX: CXO) reports on its December quarterly activities, highlighting significant cash reserves, exploration success, and director appointment.
Praemium Limited (ASX:PPS) reports a 29% increase in FUA to $62.1 billion, highlighting strong growth metrics and inflows for Q2 FY2025.
Firebrick Pharma Ltd reports significant operational and financial updates, marking progress in Singapore sales of Nasodine during the December quarter.
Sovereign Metals Limited announces the results of the Optimised Pre-feasibility Study for the Kasiya Rutile-Graphite Project, highlighting strong economic potential.
Zoono Group Limited reports strong interest in shelf-life extension technology with expanding trials and a positive financial outlook for 2025.
Archer Materials (ASX:AXE) has secured a key US patent for its Biochip technology, enhancing its prospects in the medical diagnostics market.
LTR Pharma Limited (ASX:LTP) partners with Symbion for nationwide distribution of SPONTANĀ®, enhancing access and operational capabilities.
Emyria Limited (ASX:EMD) announces leadership changes to bolster its growth in mental health treatments.
Evolution Mining (ASX:EVN) reports substantial cash flow growth and a strong operational performance in its December quarter, with significant achievements in safety and exploration.